Back to search
FDAFDA · Food and drugs·Recall number D-315-2013

QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02

Published May 15, 2013 · Recall initiated: February 26, 2013

Summary

FDA records drug Class II recall D-315-2013, published May 15, 2013 and initiated February 26, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 139,200 vials; Lot: Lot 21-480-EV Exp.12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

What to do

Voluntary: Firm initiated · Letter

Get an email if QUELICIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
QUELICIN
Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot 21-480-EV Exp.12/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02 recalled?

Yes. FDA published recall D-315-2013 on May 15, 2013. Reported hazard: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: QUELICIN.